Pharming N.V.(PHAR) - 2023 Q4 - Earnings Call Transcript

Pharming Group N.V. (NASDAQ:PHAR) Q4 2023 Earnings Conference Call March 14, 2024 8:30 AM ET Company Participants Sijmen de Vries - Chief Executive Officer Stephen Toor - Chief Commercial Officer Anurag Relan - Chief Medical Officer Jeroen Wakkerman - Chief Financial Officer Conference Call Participants Christian Glennie - Stifel Alistair Campbell - Royal Bank of Canada Joe Pantginis - H.C. Wainwright Simon Scholes - First Berlin Operator Good day and thank you for standing by. Welcome to the Pharming Group ...